In both CR conditions, participants lost significant fat mass (CRP − 0.5 ± 0.1 kg, p < 0.01; CRC − 0.6 ± 0.2 kg, p < 0.001) and lean mass (CRP − 1.3 ± 0.3 kg, p < 0.001; CRC − 1.4 ± 0.2 kg, p = 0.001). This evidence concerns the gene CRP and colorectal carcinoma.